Hariharan Subramanian becomes new MD of Siemens Healthcare

Published On 2023-07-04 07:28 GMT | Update On 2023-07-04 07:28 GMT

Mumbai:Hariharan Subramanian (49) has been named as the Managing Director of Siemens Healthcare Private Limited, India, effective July 1, 2023.Siemens Healthcare Private Limitedis the wholly owned subsidiary company of the global MedTech company, Siemens Healthineers AG (listed in Frankfurt, Germany: SHL).

He leads the business for Siemens Healthineers India including, manufacturing, sales, and distribution, strategy for “Zone India”, comprising neighboring countries like Bangladesh, Nepal, Sri Lanka, Bhutan, and Maldives.

During his association of over 25 years with Siemens, he has held leadership positions in Finance, Business Administration, Enterprise Services, and Sales functions across Software engineering, IT Consulting, and Healthcare business.

Before assuming responsibilities of Zone India in May 2023, he was the Head of Sales for the Diagnostic Imaging and Advanced Therapy businesses in India. He has been leading the team in Zone India towards the common goal of pioneering breakthroughs in healthcare, for everyone, everywhere, so that therapy becomes more precise and affordable.

Siemens Healthineers in India has a countrywide sales network and round-the-clock service set-up, two manufacturing facilities at Vadodara for Diagnostics and at Bengaluru for Medical Imaging Products, backed by a state-of-the-art R&D center as well as a global software development center at Bengaluru.

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Hariharan Subramanian becomes new MD of Siemens Healthcare

Similar News

Alembic Pharma gets USFDA nod for Phytonadione Injectable Emulsion for hypoprothrombinemia due to vitamin K deficiency

Russia's Enteromix Cancer Vaccine Shows 100% Success in Trial, Awaits Final Nod for Public Use

Mankind Pharma wins CDSCO nod to start Phase 1 trials of Autoimmune drug candidate

India seeks to boost drug exports to semi regulated markets in Africa, Latin America, Southeast Asia

Jubilant Ingrevia appoints Sonia Dharap as Vice President - Sales, Business Development (US)

EMA warns of sharp rise in illegal medicines sold in EU

Indegene opens new center in Pune, boosts India presence

Indian medical devices share increased from 10% to 30% of domestic requirements in last 5 years: DoP Secretary